| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
4,237 |
3,057 |
$176K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
4,402 |
3,111 |
$131K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
2,645 |
2,229 |
$91K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
2,032 |
1,520 |
$90K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,363 |
914 |
$20K |
| 87428 |
|
117 |
89 |
$4K |
| 99385 |
|
55 |
39 |
$3K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
90 |
70 |
$3K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
50 |
32 |
$2K |
| 80305 |
|
258 |
169 |
$2K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
51 |
43 |
$1K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
21 |
13 |
$730.92 |
| 36415 |
Collection of venous blood by venipuncture |
324 |
233 |
$476.53 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
37 |
14 |
$391.80 |
| 81025 |
|
56 |
41 |
$233.23 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
555 |
391 |
$214.52 |
| J0945 |
Injection, brompheniramine maleate, per 10 mg |
199 |
134 |
$211.91 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
24 |
17 |
$172.90 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
626 |
436 |
$49.93 |